Large Language Models

variational.ai

Variational AI uses generative AI for drug discovery, partnering with biopharmaceutical companies.

Source rating 5.0 (79) 11k views 11k/mo traffic 0 saves Unknown
More categories (8)

Verdict

A quick read before you dig into the full page.

Best if
You are medicinal chemists and need: Accelerating the discovery of brain-penetrant ATR inhibitors
Pick this when
Variational AI uses generative AI for drug discovery, partnering with biopharmaceutical companies

Overview

Variational AI is a company that uses advanced generative AI for drug discovery. They collaborate with biopharmaceutical partners to develop new therapeutics across various disease areas, aiming to positively impact lives. Their Enki™ Platform is a commercially accessible foundation model for small molecules, trained on a vast amount of experimental data. They focus on creating novel and selective lead structures quickly, without requiring initial data, by defining the Target Product Profile (TPP).

variational.ai screenshot

Best for

Short scenarios where variational.ai tends to shine.

  • Accelerating the discovery of brain-penetrant ATR inhibitors

    Best for Medicinal chemists

  • Designing novel molecules for previously undruggable targets

    Best for Computational chemists

  • Redefining the unit economics of drug discovery and development

    Best for Drug discovery researchers

Example outputs 1

Sample generations and before/after results for variational.ai.

Access & connections

Where you can use variational.ai.

Platforms

Web

Capabilities

What this tool accepts, produces, and is strongest at.

Highlights

  • Generative AI for drug discovery
  • Enki™ Platform for small molecule design
  • Target Product Profile (TPP) definition
  • Collaboration with biopharmaceutical partners

People also view

Tools that often show up alongside variational.ai in collections and comparisons.

FAQ 5

What is Variational AI?
Variational AI is a company that uses advanced generative AI for drug discovery. They collaborate with biopharmaceutical partners to develop new therapeutics across various disease areas, aiming to positively impact lives. Their Enki™ Platform is a commercially accessible foundation model for small molecules, trained on a vast amount of experimental data. They focus on creating novel and selective lead structures quickly, without requiring initial data, by defining the Target Product Profile (TPP).
How to use Variational AI?
To use Variational AI's Enki™ platform, define your Target Product Profile (TPP) by selecting on-target(s), off-target(s), and other desired properties. The platform then uses its ensemble of generative algorithms to create novel and selective lead structures.
What is the Enki™ Platform?
The Enki™ Platform is the first commercially accessible foundation model for small molecules developed by Variational AI. It uses generative algorithms trained on decades of experimental data to design novel drug-like molecules.
What is a Target Product Profile (TPP)?
A Target Product Profile (TPP) defines the desired characteristics of a new therapeutic, including on-targets, off-targets, and other properties. Variational AI's Enki™ platform uses the TPP to guide the design of novel molecules.
What kind of targets does Enki support?
Enki is trained on more than 570 targets across more than 10 target classes, including GPCRs, kinases, hydrolases, proteases, NHRs, and integrins, with more being added regularly.
variational.ai